Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-02 Sale | 2024-05-06 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 1,799 | $23.31 | $41,935 | 30,205 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 4,720 | $38.1 | $179,813 | 32,001 (Direct) | View |
| 2023-09-28 Sale | 2023-10-02 5:51 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 1,550 | $26.33 | $40,812 | 21,734 (Direct) | View |
| 2021-02-04 Sale | 2021-02-05 4:32 pm | Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer | 817 | $11.21 | $9,159 | 52,685 (Direct) | View |
| 2021-01-25 Sale | 2021-01-27 8:42 pm | Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer | 599 | $11.41 | $6,835 | 27,982 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-21 11:18 am | N/A 2034-06-19 | CHIMERIX INC | CMRX | Vakiener Victoria Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:52 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 14,987 | $25.41 | 36,721 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-12 4:25 pm | N/A 2033-06-08 | CHIMERIX INC | CMRX | Vakiener Victoria Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:35 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 12,460 | $0 | 27,877 (Direct) | View |
| 2023-01-10 Disposition | 2023-01-11 8:35 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 1,764 | $0 | 27,877 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 11:14 am | N/A 2032-06-22 | CHIMERIX INC | CMRX | Vakiener Victoria Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2022-05-05 6:15 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 0 | $0 | 17,181 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-25 5:19 pm | N/A 2031-06-22 | CHIMERIX INC | CMRX | Vakiener Victoria Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-04-22 Option Award | 2021-04-26 5:10 pm | N/A 2031-04-21 | CHIMERIX INC | CMRX | Vakiener Victoria Director | 60,000 | $0 | 60,000 (Direct) | View |
Ownership | 2021-04-26 5:08 pm | N/A N/A | CHIMERIX INC | CMRX | Vakiener Victoria Director | 0 | $0 | 0 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-02 9:05 pm | N/A 2031-01-31 | Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer | 147,274 | $0 | 175,256 (Direct) | View |
Ownership(A) | 2021-01-27 8:31 pm | N/A N/A | Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer | 0 | $0 | 28,581 (Direct) | View |
Ownership | 2020-09-28 4:15 pm | N/A N/A | Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer | 0 | $0 | 208,424 (Direct) | View |